Related references
Note: Only part of the references are listed.New circulating biomarkers for prostate cancer
K. Bensalah et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2008)
Serum GFAP is a diagnostic marker for glioblastoma multiforme
C. S. Jung et al.
BRAIN (2007)
Insulin-like growth factor binding protein 2 promotes glioma development and progression
Sarah M. Dunlap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Prognostic significance of co-overexpression of the EGFR/IGFBP-2/HIF-2A genes in astrocytomas
Carlos A. Scrideli et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24
Tsuyoshi Fukushima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
IQGAP1 and IGFBP2: Valuable biomarkers for determining prognosis in glioma patients
Kerrie L. McDonald et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K-Akt pathway activation in glioblastoma and prostate cancer
R. Mehrian-Shai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Management of asymptornatic patients on follow-up for ovarian cancer with rising CA-125 concentrations
Tyronne I. Goonewardene et al.
LANCET ONCOLOGY (2007)
Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator
A. Juncker-Jensen et al.
GROWTH HORMONE & IGF RESEARCH (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML
K Dawczynski et al.
BONE MARROW TRANSPLANTATION (2006)
Cathepsin D is a potential serum marker for poor prognosis in glioma patients
ME Fukuda et al.
CANCER RESEARCH (2005)
Significant expression of IGFBP2 in breast cancer compared with benign lesions
LT Busund et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of alioma cell invasion
SW Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas
GS Bauman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
